Summit Street Capital Management’s Gilead Sciences GILD Stock Holding History

Summit Street Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25,064	Closed	-$1.84M	–	30
2024 Q1	$1.84M	Hold	25,064	–	–	0.71%	30
2023 Q4	$2.03M	Hold	25,064	–	–	0.86%	29
2023 Q3	$1.88M	Sell	25,064 -22,800	-48%	-$1.75M	0.84%	31
2023 Q2	$3.69M	Sell	47,864 -7,363	-13%	-$587K	1.74%	31
2023 Q1	$4.58M	Hold	55,227	–	–	2.44%	26
2022 Q4	$4.74M	Hold	55,227	–	–	2.99%	12
2022 Q3	$3.41M	Hold	55,227	–	–	2.36%	21
2022 Q2	$3.41M	Hold	55,227	–	–	2.24%	21
2022 Q1	$3.28M	Hold	55,227	–	–	1.99%	23
2021 Q4	$4.01M	Hold	55,227	–	–	2.5%	19
2021 Q3	$3.86M	Hold	55,227	–	–	2.56%	23
2021 Q2	$3.8M	Buy	55,227 +12,804	+30%	+$855K	2.44%	22
2021 Q1	$2.74M	Buy	+42,423	New	+$2.74M	1.78%	26
2020 Q4	–	Sell	-29,792	Closed	-$1.88M	–	35
2020 Q3	$1.88M	Hold	29,792	–	–	1.67%	28
2020 Q2	$2.29M	Hold	29,792	–	–	1.92%	27
2020 Q1	$2.23M	Buy	+29,792	New	+$2.06M	2.41%	22
2018 Q4	–	Sell	-48,492	Closed	-$3.74M	–	33
2018 Q3	$3.74M	Hold	48,492	–	–	3.65%	8
2018 Q2	$3.44M	Hold	48,492	–	–	3.33%	12
2018 Q1	$3.66M	Hold	48,492	–	–	3.62%	9
2017 Q4	$3.47M	Hold	48,492	–	–	3.43%	13
2017 Q3	$3.93M	Hold	48,492	–	–	4.49%	3
2017 Q2	$3.43M	Hold	48,492	–	–	3.95%	7
2017 Q1	$3.29M	Buy	48,492 +7,283	+18%	+$512K	3.61%	8
2016 Q4	$2.95M	Buy	41,209 +6,955	+20%	+$517K	3.28%	12
2016 Q3	$2.71M	Buy	34,254 +1,785	+5%	+$145K	2.91%	15
2016 Q2	$2.71M	Buy	32,469 +157	+0.5%	+$13.9K	3.02%	13
2016 Q1	$2.97M	Buy	32,312 +1,300	+4%	+$117K	3.09%	11
2015 Q4	$3.14M	Buy	31,012 +10,600	+52%	+$1.1M	3.55%	8
2015 Q3	$2M	Buy	+20,412	New	+$2.27M	2.38%	26

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Street Capital Management's GILD Position: Q2 2024 in Review

Summit Street Capital Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 25,064 shares — an estimated $1.84M sold.

Summit Street Capital Management first reported a position in GILD in Q3 2015 and held it in 29 quarters. The position peaked at $4.74M in Q4 2022. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Summit Street Capital Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Summit Street Capital Management sold 25,064 Gilead Sciences shares in Q2 2024, an estimated $1.84M.
Summit Street Capital Management first reported a position in Gilead Sciences in Q3 2015 and held it in 29 quarters.
Summit Street Capital Management's Gilead Sciences position peaked at $4.74M in Q4 2022.
1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Summit Street Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.